DOI: 10.1128/AAC.02374-17
Article Information
PubMed
Published By
History
- Received November 20, 2017
- Returned for modification December 18, 2017
- Accepted January 27, 2018
- Published online March 27, 2018.
Copyright & Usage
Copyright © 2018 American Society for Microbiology. All Rights Reserved.
Article Versions
- Accepted Manuscript version (February 05, 2018).
- You are viewing the most recent version of this article.
Author Information
- Ronald Domalaona,
- Yaroslav Sanchaka,
- Linet Cherono Koskeib,c,
- Yinfeng Lyua,d,
- George G. Zhanele,
- Gilbert Arthurb and
- Frank Schweizera,e
- aDepartment of Chemistry, University of Manitoba, Winnipeg, Manitoba, Canada
- bDepartment of Biochemistry and Medical Genetics, University of Manitoba, Winnipeg, Manitoba, Canada
- cSchool of Biological Sciences, University of Nairobi, Nairobi, Kenya
- dInstitute of Animal Nutrition, Northeast Agricultural University, Harbin, Heilongjiang, People's Republic of China
- eDepartment of Medical Microbiology and Infectious Diseases, University of Manitoba, Winnipeg, Manitoba, Canada
- Address correspondence to Frank Schweizer, schweize{at}cc.umanitoba.ca.
Citation Domalaon R, Sanchak Y, Koskei LC, Lyu Y, Zhanel GG, Arthur G, Schweizer F. 2018. Short proline-rich lipopeptide potentiates minocycline and rifampin against multidrug- and extensively drug-resistant Pseudomonas aeruginosa. Antimicrob Agents Chemother 62:e02374-17. https://doi.org/10.1128/AAC.02374-17.
